Published Date : 24 Jan 20 | Views: 64 | Industry : Life Science
Harmful Effects of Pollution on Eyes is Likely to Boost the Growth of the Dry Eyes Treatment Segment
The application segment is bifurcated into Contact Lenses Moisten, Dry Eyes Treatment, and Others. The increasing number in cases of dry eyes syndrome is due to harmful effects of pollution and because of strain on eyes as a result of continued exposure to digital light. Rising cases of chronic conjunctivitis, which need proper treatment and prescribed medicine are likely to boost the growth of the dry eyes treatment segment. The product segment of the market is classified into Artificial Tear Ointment and Artificial Tear Liquid.
Asia-Pacific Market is Projected to be the Most Lucrative Market
The availability of a variety of products at affordable prices is likely to fuel the growth of the market in the Asia-Pacific region. The region is also witnessing a rise in aging population, which has a high rate of patients suffering from the condition of dry eyes. This is likely to foster the growth of the market over the next few years.
Manufactures are Keen to Improve and Develop Novel Products
Market players are involved in developing innovative products to offer improved patient care.
For instance, in 2017, Human Medicinal Products (CHMP) approved a product developed by Santen Pharmaceuticals for the treatment of Severe Vernal Keratoconjunctivitis, particularly for marketing in Europe.
Alcon, Allergan, Abbott, Ursapharm, Santen Pharmaceutical, Bausch & Lomb, Ocusoft, Johnson & Johnson, Sintong, Nicox, Wuhn Yuand, and Similasan are major companies that are functioning in the market.
Increasing Cases of Dry Eyes is Driving the Growth of the Artificial Tears Market
Artificial Tears commonly known as lubricant eye drops have evolved as a solution for patients suffering from severe to the moderate condition of dry eyes. These eye drops have a huge demand as they are also used to moisten contact lenses. Artificial Tears has a major application in treating eye condition due to deficiency in tear production also known as keratoconjunctivitis sicca. Manufacturers are introducing eye drops that are free of preservatives to address the issues of inflammation for patients who require regular usage. Advances in technology is promoting the development of Artificial Tears without side-effects, which is likely to drive the growth of the Artificial Tears market.